Survival Prediction for Patients with Metastatic Cancer
Prospective Validation of a Points Score System Predicting 30-day Survival
Recruiting
Observational Study
Metastatic Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 214 (estimated)
- Sponsor
- Indiana University · Other
Who this trial is looking for
This trial is looking for patients with metastatic cancer who are getting palliative radiation therapy. Participants will have their survival chances predicted using a scoring system based on their health data.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old
- I can give written consent
- I have a cancer diagnosis and need palliative radiation therapy
- I can choose not to receive radiation therapy
- I may stop my radiation treatment early and still participate
You may not be able to join if
- I cannot follow up with the study as needed
- I am receiving treatment aimed at curing my cancer
- I am pregnant or nursing
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This is a one-stage single-arm phase II clinical trial designed to prospectively test the survival prediction tool as developed by Lee et al on patients referred to radiation oncology for palliative treatments. Survival prediction score based on objective data including laboratory values, attendance to emergency room, and primary cancer origin will be assigned to each patient at time of enrollment…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age ≥ 18 at time of consent
2. Ability to provide written informed consent
3. Cancer diagnosis referred to Radiation Oncology for palliative radiation therapy
4. Patients who either choose to not receive radiation therapy or not recommended to receive radiation therapy will r…